Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Remifentanil vs Nicardipine for Controlled Hypotension in Nasal Surgery
NCT07660562Not yet recruiting
- Sponsor
- Gazi Yaşargil Training and Research Hospital
- Start
- Jun 2026
- Primary completion
- Jul 2026
01
Overview
Randomised, single-blind trial of nicardipine in nasal surgery (2 arms), sponsored by Gazi Yaşargil Training and Research Hospital. Primary endpoint: Surgical Field Quality (Fromme-Boezaart score) up to 3 hours. Planned start Jun 2026; status: not yet recruiting.
02
Drugs
nicardipine
03
Conditions
nasal surgery
Beyond the preview
Go deeper on NCT07660562.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07660562.